Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025)

Protara Therapeutics (TARA) recorded quarterly Other Non Operating Income of $249000.0 in Q4 2025, down 48.23% quarter-over-quarter from $481000.0 in Q1 2025.

Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025) Analysis & Trends

Protara Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $249000.0 for Q4 2025.

  • In Q4 2025, Other Non Operating Income changed N/A year-over-year to $249000.0; the TTM figure through Dec 2025 stood at $730000.0 (changed N/A YoY), while the FY2025 annual figure was $730000.0, up 88.63% from the prior year.
  • Other Non Operating Income was $249000.0 for Q4 2025 at Protara Therapeutics, down from $481000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $481000.0 in Q1 2025 to a low of $249000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Protara Therapeutics 216.35 Mn 216.35 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 249,000.00
Mar 31, 2025 481,000.00
Sep 30, 2019 2,000.00
Jun 30, 2019 -2,000.00
Mar 31, 2019 1,000.00
Sep 30, 2018 -1,000.00
Jun 30, 2018 15,000.00
Mar 31, 2018 192,000.00
Sep 30, 2017 -84,000.00
Jun 30, 2017 332,000.00
Mar 31, 2017 -50,000.00
Sep 30, 2016 -4,000.00
Jun 30, 2016 -63,000.00
Mar 31, 2016 6,000.00
Dec 31, 2015 -211,000.00
Sep 30, 2015 -314,000.00
Jun 30, 2015 -112,000.00
Dec 31, 2014 10.50 Mn
Sep 30, 2014 -5.33 Mn
Jun 30, 2014 -29,000.00